These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33520050)

  • 21. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines.
    Ahn JG; Choi SY; Kim DS; Kim KH
    Infect Dis (Lond); 2015 Jun; 47(6):385-92. PubMed ID: 25712791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Makwana A; Sheppard C; Borrow R; Fry N; Andrews NJ; Ladhani SN
    Pediatr Infect Dis J; 2018 Jul; 37(7):697-703. PubMed ID: 29889811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beneficial effects of weekly low-dose vitamin A supplementation on acute lower respiratory infections and diarrhea in Ecuadorian children.
    Sempértegui F; Estrella B; Camaniero V; Betancourt V; Izurieta R; Ortiz W; Fiallo E; Troya S; Rodríguez A; Griffiths JK
    Pediatrics; 1999 Jul; 104(1):e1. PubMed ID: 10390287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
    Moore CE; Paul J; Foster D; Mahar SA; Griffiths D; Knox K; Peto TE; Walker AS; Crook DW;
    J Infect Dis; 2014 Oct; 210(7):1001-11. PubMed ID: 24719477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
    Shi T; McAllister DA; O'Brien KL; Simoes EAF; Madhi SA; Gessner BD; Polack FP; Balsells E; Acacio S; Aguayo C; Alassani I; Ali A; Antonio M; Awasthi S; Awori JO; Azziz-Baumgartner E; Baggett HC; Baillie VL; Balmaseda A; Barahona A; Basnet S; Bassat Q; Basualdo W; Bigogo G; Bont L; Breiman RF; Brooks WA; Broor S; Bruce N; Bruden D; Buchy P; Campbell S; Carosone-Link P; Chadha M; Chipeta J; Chou M; Clara W; Cohen C; de Cuellar E; Dang DA; Dash-Yandag B; Deloria-Knoll M; Dherani M; Eap T; Ebruke BE; Echavarria M; de Freitas Lázaro Emediato CC; Fasce RA; Feikin DR; Feng L; Gentile A; Gordon A; Goswami D; Goyet S; Groome M; Halasa N; Hirve S; Homaira N; Howie SRC; Jara J; Jroundi I; Kartasasmita CB; Khuri-Bulos N; Kotloff KL; Krishnan A; Libster R; Lopez O; Lucero MG; Lucion F; Lupisan SP; Marcone DN; McCracken JP; Mejia M; Moisi JC; Montgomery JM; Moore DP; Moraleda C; Moyes J; Munywoki P; Mutyara K; Nicol MP; Nokes DJ; Nymadawa P; da Costa Oliveira MT; Oshitani H; Pandey N; Paranhos-Baccalà G; Phillips LN; Picot VS; Rahman M; Rakoto-Andrianarivelo M; Rasmussen ZA; Rath BA; Robinson A; Romero C; Russomando G; Salimi V; Sawatwong P; Scheltema N; Schweiger B; Scott JAG; Seidenberg P; Shen K; Singleton R; Sotomayor V; Strand TA; Sutanto A; Sylla M; Tapia MD; Thamthitiwat S; Thomas ED; Tokarz R; Turner C; Venter M; Waicharoen S; Wang J; Watthanaworawit W; Yoshida LM; Yu H; Zar HJ; Campbell H; Nair H;
    Lancet; 2017 Sep; 390(10098):946-958. PubMed ID: 28689664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
    Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
    Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.
    Shi T; Balsells E; Wastnedge E; Singleton R; Rasmussen ZA; Zar HJ; Rath BA; Madhi SA; Campbell S; Vaccari LC; Bulkow LR; Thomas ED; Barnett W; Hoppe C; Campbell H; Nair H
    J Glob Health; 2015 Dec; 5(2):020416. PubMed ID: 26682048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
    Dunn MG; Lessa FC; Sánchez J; Cordero R; Feris-Iglesias J; Cedano D; Carvalho MDG; Fernández J; Feemster KA
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S237-S247. PubMed ID: 34469551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Faye PM; Sonko MA; Diop A; Thiongane A; Ba ID; Spiller M; Ndiaye O; Dieye B; Mwenda JM; Sow AI; Diop B; Diallo A; Farrar JL
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S66-S71. PubMed ID: 31505625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children.
    Lehmann D; Marshall TF; Riley ID; Alpers MP
    Ann Trop Paediatr; 1991; 11(3):247-57. PubMed ID: 1719924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
    Ricketson LJ; Conradi NG; Vanderkooi OG; Kellner JD
    Pediatr Infect Dis J; 2018 Jan; 37(1):22-27. PubMed ID: 28737622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
    Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
    Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxaemia in acute respiratory and non-respiratory illnesses in neonates and children in a developing country.
    Duke T; Blaschke AJ; Sialis S; Bonkowsky JL
    Arch Dis Child; 2002 Feb; 86(2):108-12. PubMed ID: 11827904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Child nutrition and lower respiratory tract disease burden in New Zealand: a global context for a national perspective.
    Grant CC; Wall CR; Gibbons MJ; Morton SM; Santosham M; Black RE
    J Paediatr Child Health; 2011 Aug; 47(8):497-504. PubMed ID: 21040074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia.
    Urbancikova I; Prymula R; Goldblatt D; Roalfe L; Prymulova K; Kosina P
    Vaccine; 2017 Sep; 35(38):5186-5193. PubMed ID: 28797727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
    Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
    Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.